AB 404: Commercial cannabis activity: testing laboratories.
- Session Year: 2019-2020
- House: Assembly
- Latest Version Date: 2019-10-12
|
Date
|
Status
|
|---|---|
| Oct 12, 2019 | Chaptered by Secretary of State - Chapter 799, Statutes of 2019. |
| Oct 12, 2019 | Approved by the Governor. |
| Sep 11, 2019 | Enrolled and presented to the Governor at 3:30 p.m. |
| Sep 6, 2019 | In Assembly. Ordered to Engrossing and Enrolling. |
| Sep 5, 2019 | Read third time. Passed. Ordered to the Assembly. |
| Aug 30, 2019 | From committee: Do pass. (Ayes 7. Noes 0.) (August 30). |
| Jun 24, 2019 | In committee: Referred to APPR. suspense file. |
| Jun 3, 2019 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 9. Noes 0.) (June 3). Re-referred to Com. on APPR. |
| May 8, 2019 | Referred to Com. on B., P. & E.D. |
| Apr 25, 2019 | In Senate. Read first time. To Com. on RLS. for assignment. |
| Apr 25, 2019 | Read third time. Passed. Ordered to the Senate. |
| Apr 11, 2019 | Read second time. Ordered to Consent Calendar. |
| Apr 10, 2019 | From committee: Do pass. To Consent Calendar. (Ayes 17. Noes 0.) (April 10). |
| Apr 2, 2019 | From committee: Do pass and re-refer to Com. on APPR. (Ayes 20. Noes 0.) (April 2). Re-referred to Com. on APPR. |
| Mar 20, 2019 | Re-referred to Com. on B. & P. |
| Mar 19, 2019 | From committee chair, with author's amendments: Amend, and re-refer to Com. on B. & P. Read second time and amended. |
| Feb 21, 2019 | Referred to Com. on B. & P. |
| Feb 7, 2019 | From printer. May be heard in committee March 9. |
| Feb 6, 2019 | Read first time. To print. |
|
Date
|
Description
|
Location
|
Votes
|
|
|---|---|---|---|---|
| Sep 5, 2019 | Assembly 3rd Reading AB404 Mark Stone et al. By Hill | Senate Floor |
Passed |
|
| Aug 30, 2019 | Do pass | Senate Standing Committee on Appropriations |
Passed |
|
| Jun 24, 2019 | Placed on suspense file | Senate Standing Committee on Appropriations |
Passed |
|
| Jun 3, 2019 | Do pass, but first be re-referred to the Committee on [Appropriations] | Senate Standing Committee on Business, Professions and Economic Development |
Passed |
|
| Apr 25, 2019 | AB 404 Mark Stone Consent Calendar Second Day Regular Session | Assembly Floor |
Passed |
|
| Apr 10, 2019 | Do pass. To Consent Calendar. | Assembly Standing Committee on Appropriations |
Passed |
|
| Apr 2, 2019 | Do pass and be re-referred to the Committee on [Appropriations] | Assembly Standing Committee on Business and Professions |
Passed |
This list shows positions taken on this bill by organizations on the date displayed, which is linked to the original source.
Positions by individuals are not included.
Office of Senate Floor Analyses (916) 651-1520 Fax: (916) 327-4478 | AB 404 |
THIRD READING
Bill No: AB 404
Author: Mark Stone (D), et al.
Amended: 3/19/19 in Assembly
SENATE BUS., PROF. & ECON. DEV. COMMITTEE: 9-0, 6/3/19
AYES: Glazer, Chang, Archuleta, Dodd, Galgiani, Hill, Leyva, Pan, Wilk
SENATE APPROPRIATIONS COMMITTEE: 7-0, 8/30/19
AYES: Portantino, Bates, Bradford, Durazo, Hill, Jones, Wieckowski
ASSEMBLY FLOOR: 76-0, 4/25/19 (Consent) - See last page for vote
SUBJECT: Commercial cannabis activity: testing laboratories
SOURCE: California Cannabis Industry Association
Etheridge Farms
DIGEST:
This bill authorizes a cannabis testing laboratory to amend a certificate of analysis (COA) to correct minor errors and retest samples, as specified.
ANALYSIS:
Existing law:
- Establishes the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) to regulate the cultivation, distribution, transport, storage, manufacturing, processing, and sale of both medicinal and adult-use cannabis. (Business and Professions Code (BPC) § 26000)
- Prohibits the sale of cannabis or cannabis products unless a representative sample of the cannabis or cannabis products has been tested by a licensed testing laboratory. (BPC § 26100 (a))
- States that, if a test result falls outside the specifications authorized by law or regulation, the testing laboratory shall follow a standard operating procedure to confirm or refute the original result. (BPC § 26100 (h))
- Requires a testing laboratory to issue a COA, as specified, for selected lots of each batch tested, at a frequency determined by the Bureau of Cannabis Control (Bureau), with specified information. (BPC § 26100 (d))
- Allows a cannabis goods batch that fails testing to be remediated twice by additional processing. (16 CCR § 5727 (a))
- Requires the destruction, and prohibits the retesting, of cannabis goods that cannot be remediated or reprocessed in any way. (16 CCR § 5727 (b-c))
- States that any COAs produced without remediation or reprocessing of the failed batch will not supersede the initial regulatory compliance testing COA. (16 CCR § 5727 (d))
This bill:
- Authorizes a testing laboratory to amend a COA to correct minor errors, as defined by the Bureau.
- Authorizes the testing laboratory to retest a sample whose test result falls outside the specifications authorized by law or regulation, if both of the following occur:
- The testing laboratory notifies the Bureau, in writing, that the test was compromised due to equipment malfunction, staff error, or other circumstances allowed by the Bureau.
- The Bureau authorizes the testing laboratory to retest the sample.
- Makes legislative findings and declarations.
Background
The Legislature passed the Medical Cannabis Regulation and Safety Act (MCRSA) in 2015. MCRSA established for the first time, a comprehensive statewide licensing and regulatory framework for the cultivation, manufacture, transportation, testing, distribution, and sale of medicinal cannabis to be administered by the Bureau within Department of Consumer Affairs, Department of Public Health, and the Department of Food and Agriculture (CDFA). Shortly following the passage of MCRSA in November 2016, California voters passed Proposition 64, the "Control, Regulate and Tax Adult Use of Marijuana Act" (Proposition 64), which legalized adult-use cannabis.
Less than a year later in June 2017, the California State Legislature passed a Budget Trailer Bill, SB 94 (Committee on Budget and Fiscal Review, Chapter 27, Statutes of 2017), that integrated MCRSA with Proposition 64 to create MAUCRSA, the current regulatory structure for both medicinal and adult-use cannabis.
MAUCRSA requires cannabis in its final form to be laboratory tested prior to sale. In addition to information pertaining to the product’s chemical profiles and contaminants, the COA documents administrative information about the laboratory, the distributor or microbusiness, dates and signatures, and other non-testing data which can be subject to simple data entry mistakes. Once issued, current law prohibits amending a COA or retesting samples, and the cannabis must be either remediated or destroyed. (However, the Bureau has indicated that, in limited circumstances, it has allowed a failed batch to be re-sampled and re-tested with another laboratory when the original laboratory clearly failed to meet quality control acceptance criteria.)
This bill allows the Bureau to determine which errors may be corrected on a COA and authorizes the testing laboratory to retest samples upon notification and approval by the Bureau, thereby preserving product and process integrity.
FISCAL EFFECT: Appropriation: No Fiscal Com.: Yes Local: No
According to the Senate Appropriations Committee, the Department of Consumer Affairs estimates $122,000 (Cannabis Control Fund) in FY 2020-21, and $114,000 (Cannabis Control Fund) in FY 2021-22, and ongoing, for 1.0 Environmental Scientist in the Bureau’s laboratory testing unit. Absorbable workload for the Bureau to promulgate regulations as to what constitutes a “minor error.” No anticipated information technology impact to the Bureau.
The CDFA estimates approximately $100,000 (Cannabis Control Fund) to $200,000 (Cannabis Control Fund) to update the current Track and Trace System, but notes these could vary, absent knowing the scope and detail of specified requirements. For example, the update to the system would need to clarify the acceptability regarding retests or revisions of COAs, and system requirements would be based on new Bureau regulations, which have not yet been developed.
California Cannabis Industry Association (co-source)
Etheridge Farms (co-source)
Drug Policy Alliance
NorCal Cannabis
Southern California Coalition
OPPOSITION: (Verified 8/30/19)
None received
ARGUMENTS IN SUPPORT: Supporters note that this bill offers a simple, straightforward solution by allowing cannabis testing laboratories to submit a form to correct minor errors related to laboratory testing.
ASSEMBLY FLOOR: 76-0, 4/25/19
AYES: Aguiar-Curry, Bauer-Kahan, Berman, Bigelow, Bloom, Boerner Horvath, Bonta, Brough, Burke, Calderon, Carrillo, Cervantes, Chau, Chiu, Choi, Chu, Cooley, Cooper, Cunningham, Dahle, Daly, Diep, Eggman, Flora, Fong, Frazier, Friedman, Gabriel, Gallagher, Cristina Garcia, Gipson, Gloria, Gonzalez, Grayson, Holden, Irwin, Jones-Sawyer, Kalra, Kamlager-Dove, Kiley, Lackey, Levine, Limón, Low, Maienschein, Mathis, Mayes, McCarty, Medina, Melendez, Mullin, Muratsuchi, Nazarian, Obernolte, O'Donnell, Patterson, Petrie-Norris, Quirk, Quirk-Silva, Ramos, Reyes, Luz Rivas, Robert Rivas, Rodriguez, Blanca Rubio, Salas, Santiago, Smith, Mark Stone, Ting, Voepel, Waldron, Weber, Wicks, Wood, Rendon
NO VOTE RECORDED: Arambula, Chen, Eduardo Garcia, Gray
Prepared by: Elissa Silva / B., P. & E.D. / 916-651-4104
9/1/19 10:14:04
**** END ****
SENATE COMMITTEE ON APPROPRIATIONS
Senator Anthony Portantino, Chair
2019 - 2020 Regular Session
AB 404 (Mark Stone) - Commercial cannabis activity: testing laboratories
Version: March 19, 2019 | Policy Vote: B., P. & E.D. 9 - 0 |
Urgency: No | Mandate: No |
Hearing Date: June 24, 2019 | Consultant: Samantha Lui |
Bill Summary:
Assembly Bill 404 would authorize a testing laboratory to amend a certificate of analysis to correct minor errors, as defined by the Bureau of Cannabis Control (Bureau), and would specify re-test procedures if a test result falls outside specifications.
Fiscal Impact:
The Department of Consumer Affairs estimates $122,000 (Cannabis Control Fund) in FY 2020-21, and $114,000 (Cannabis Control Fund) in FY 2021-22, and ongoing, for 1.0 Environmental Scientist in the Bureau’s laboratory testing unit. Absorbable workload for the Bureau to promulgate regulations as to what constitutes a “minor error.” No anticipated IT impact to the Bureau.
The Department of Food and Agriculture estimates approximately $100,000 (Cannabis Control Fund) to $200,000 (Cannabis Control Fund) to update the current Track and Trace System, but notes these could vary, absent knowing the scope and detail of specified requirements. For example, the update to the system would need to clarify the acceptability regarding retests or revisions of Certificates of Analysis (COAs), and system requirements would be based on new BCC regulations, which have not yet been developed.
Background:
In June 2015, Governor Brown signed the Medical Marijuana Regulation and Safety Act, comprised of Assembly Bill 243 (Wood), Chapter 688, Statutes of 2015; Assembly Bill 266 (Bonta), Chapter 689, Statutes of 2015; and Senate Bill 643 (McGuire), Chapter 719, Statutes of 2015. Together, these bills established the oversight and regulatory framework for the cultivation, manufacture, transportation, storage, and distribution of medical marijuana in California. The CDFA CalCannabis Cultivation Licensing (CalCannabis) regulates cultivation, the CDPH Manufactured Cannabis Safety Branch regulates manufacturing, and the DCA Bureau of Cannabis Control regulates distribution, testing, retail, and microbusiness.
In 2017, the Legislature passed the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) that harmonized these bills and created a single-comprehensive system to control and regulation the cultivation, distribution, transport, storage, manufacturing, processing and sale of both medicinal cannabis. In 2018, California voters approved Proposition 64, the Control, Regulation and Tax Adult Use of Marijuana Act, which authorized adults aged 21 years or older to legally grow, possess, and use marijuana for non-medical purposes, under specified restrictions. Proposition 64 also provides that revenue from cannabis taxes would support youth programs, environmental protection, and law enforcement.
MAUCRSA requires cannabis in its final form to be laboratory tested prior to sale. In addition to information pertaining to the product’s chemical profiles and contaminants, the COA documents administrative information about the laboratory, the distributor or microbusiness, dates and signatures, and other non-testing data which can be subject to simple data entry mistakes. Once issued, current law prohibits amending a COA or retesting samples, and the cannabis must be either remediated or destroyed. The Bureau indicated that, in limited circumstances, it has allowed a failed batch to be re-sampled and re-tested with another laboratory when the original laboratory clearly failed to meet quality control acceptance criteria. In addition, in CDFA’s current Track and Trace system, once a certificate has been uploaded, there is no way to upload a “corrected” certificate, should there be an error on a COA.
Currently, the California Cannabis Appeals Panel does not yet have any appeals on file, as appeals pertain only to full annual licenses. At this point in program implementation, most licenses are provisional.
Proposed Law:
The bill includes the following provisions, among other provisions:
- Authorizes a testing laboratory to amend a certificate of analysis to correct minor errors, a term to be defined by the Bureau.
- Adds to the standard operating procedure to confirm or refute the original test result, a testing laboratory must conduct:
Related Legislation:
SB 67 (McGuire) would extend a temporary cannabis license issued by the California Department of Food and Agriculture if the temporary license holder submitted an application and fees for an annual license before the temporary license’s expiration date, as specified. This bill is pending hearing in the Assembly Business and Professions Committee.
Staff Comments:
One option to amend the Track and Trace system could be to build permissions in the system to only allow a corrected COA to be re-uploaded to the system when approved by the Bureau. In this circumstance, CDFA indicates a need for an auditing trail, as well as a historical lookback to store the previous COA. Depending on the frequency of changes, CDFA also may need to work with the current vendor to increase the digital storage space necessary to store more COAs than originally estimated. The current CDFA IT budget for unanticipated expenses, of which this bill would qualify, is $400,000.
-- END --
SENATE COMMITTEE ON
BUSINESS, PROFESSIONS AND ECONOMIC DEVELOPMENT
Senator Steven Glazer, Chair
2019 - 2020 Regular
Bill No: AB 404 Hearing Date: June 3, 2019
Author: | Mark Stone | ||
Version: | March 19, 2019 | ||
Urgency: | No | Fiscal: | Yes |
Consultant: | Sarah Huchel | ||
Subject: Commercial cannabis activity: testing laboratories
SUMMARY:
Authorizes a cannabis testing laboratory to amend a certificate of analysis (COA) to correct minor errors and retest samples, as specified.
Existing law:
- Establishes the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) to regulate the cultivation, distribution, transport, storage, manufacturing, processing, and sale of both medicinal and adult-use cannabis. (Business and Professions Code (BPC) § 26000)
- Establishes the Bureau of Cannabis Control (Bureau) within the Department of Consumer Affairs (DCA) to regulate cannabis with the sole authority to create, issue, deny, renew, discipline, suspend, or revoke licenses for microbusinesses, transportation, storage unrelated to manufacturing activities, distribution, testing, and sale of cannabis and cannabis products within the state. (BPC §§ 26010, 26012 (a)(1))
- Prohibits the sale of cannabis or cannabis products unless a representative sample of the cannabis or cannabis products has been tested by a licensed testing laboratory. (BPC § 26100 (a))
- States that, if a test result falls outside the specifications authorized by law or regulation, the testing laboratory shall follow a standard operating procedure to confirm or refute the original result. (BPC § 26100 (h))
- Requires a testing laboratory to issue a COA for selected lots of each batch tested, at a frequency determined by the bureau, with specified information. (BPC § 26100 (d))
- Requires a COA to contain the following information:
- The term “Regulatory Compliance Testing” in font no smaller than 14-point.
- Laboratory’s name, licensed premises address, and license number.
- Licensed distributor’s or licensed microbusiness authorized to engage in distribution’s name, licensed premises address, and license number.
- Licensed cultivator’s, licensed manufacturer’s, or licensed microbusiness’ name, licensed premises address, and license number.
- Batch number of the batch from which the sample was obtained. For cannabis goods that are already packaged at the time of sampling, the labeled batch number on the packaged cannabis goods shall match the batch number on the COA.
- Sample identifying information, including matrix type and unique sample identifiers.
- Sample history, including the date collected, the date received by the laboratory, and the date(s) of sample analyses and corresponding testing results.
- A picture of the sample of cannabis goods. If the sample is pre-packaged, the picture must include an unobstructed image of the packaging.
- For dried flower samples, the total weight of the batch, in grams or pounds, and the total weight, of the representative sample in grams.
- For cannabis product or pre-rolls samples, the total unit count of both the representative sample and the total batch size.
- Measured density of the cannabis goods.
- The analytical methods, analytical instrumentation used, and corresponding Limits of Detection and Limits of Quantitation.
- An attestation on the COA from the laboratory supervisory or management employee that specified samples were performed and met the acceptance criteria.
- Analytes detected during the analyses of the sample that are unknown, unidentified, or injurious to human health if consumed, if any.
- The date and signature of the laboratory supervisory or management employee who validated the accuracy of the information on the COA. (Title 16, California Code of Regulations (CCR) § 5726)
- Allows a cannabis goods batch that fails testing to be remediated twice by additional processing. (16 CCR § 5727 (a))
- Requires the destruction, and prohibits the retesting, of cannabis goods that cannot be remediated or reprocessed in any way. (16 CCR § 5727 (b-c))
- States that any COAs produced without remediation or reprocessing of the failed batch will not supersede the initial regulatory compliance testing COA. (16 CCR § 5727 (d))
This bill:
- Authorizes a testing laboratory to amend a COA to correct minor errors, as defined by the Bureau.
- Authorizes the testing laboratory to retest a sample whose test result falls outside the specifications authorized by law or regulation, if both of the following occur:
- The testing laboratory notifies the Bureau, in writing, that the test was compromised due to equipment malfunction, staff error, or other circumstances allowed by the Bureau.
- The Bureau authorizes the testing laboratory to retest the sample.
- Makes Legislative findings and declarations.
FISCAL EFFECT:
According to the Assembly Appropriations Committee analysis dated April 10, 2019, this bill has minor and absorbable administrative costs to the Bureau to promulgate regulations more clearly defining what constitutes a minor error.
COMMENTS:
- Purpose. This bill is sponsored by the California Cannabis Industry Association and Etheridge Farms. According to the Author, “Cannabis products undergo testing to determine concentrations of active chemicals and to ensure compliance with safety standards. The testing results are documented in certificates of analysis (COAs), but under current State regulations, a COA cannot be corrected even if it contains a minor error due to a typo or data entry mistake. Similarly, once a COA is produced, a batch of cannabis products cannot be retested, even if the testing facility is aware of equipment malfunction, miscalibration, or other staff error producing an inaccurate result. AB 404 will address these issues by allowing COAs to be amended to fix minor errors and by permitting batches of cannabis products to be retested at the written request of the testing facility and with approval by the Bureau of Cannabis Control.”
- Cannabis Regulatory Background. California first legalized cannabis for medical consumption via Proposition 215, also known as the Compassionate Use Act, in 1996. Proposition 215 protected qualified patients and primary caregivers from prosecution related to the possession and cultivation of cannabis for medicinal purposes.
The Legislature passed the Medical Cannabis Regulation and Safety Act (MCRSA) in 2015. MCRSA established for the first time, a comprehensive statewide licensing and regulatory framework for the cultivation, manufacture, transportation, testing, distribution, and sale of medicinal cannabis to be administered by the Bureau within Department of Consumer Affairs, DPH, and CDFA.
Shortly following the passage of MCRSA in November 2016, California voters passed Proposition 64, the "Control, Regulate and Tax Adult Use of Marijuana Act" (Proposition 64), which legalized adult-use cannabis.
Less than a year later in June 2017, the California State Legislature passed a budget trailer bill, SB 94 (Committee on Budget and Fiscal Review, Chapter 27, Statutes of 2017), that integrated MCRSA with Prop 64 to create MAUCRSA, the current regulatory structure for both medicinal and adult-use cannabis.
- Cannabis testing. MAUCRSA requires cannabis in its final form to be laboratory tested prior to sale. In addition to information pertaining to the product’s chemical profiles and contaminants, the COA documents administrative information about the laboratory, the distributor or microbusiness, dates and signatures, and other non-testing data which can be subject to simple data entry mistakes. Once issued, current law prohibits amending a COA or retesting samples, and the cannabis must be either remediated or destroyed. (However, the Bureau has indicated that, in limited circumstances, it has allowed a failed batch to be re-sampled and re-tested with another laboratory when the original laboratory clearly failed to meet quality control acceptance criteria.)
This bill would allow the Bureau to determine which errors may be corrected on a COA and authorizes the testing laboratory to retest samples upon notification and approval by the Bureau, thereby preserving product and process integrity.
- Related legislation. SB 67 (McGuire) extends a temporary cannabis license issued by the California Department of Food and Agriculture if the temporary license holder submitted an application and fees for an annual license before the temporary license’s expiration date, as specified. (Status: This bill is pending in the Assembly Committee on Agriculture.)
SB 475 (Skinner) establishes the conditions under which a cannabis licensee may designate cannabis or a cannabis product as a trade sample. (Status: This bill is pending at the Assembly desk.)
AB 833 (Lackey) authorizes the Bureau to establish additional security requirements for vehicles carrying one million dollars ($1,000,000) or more of cannabis, cannabis products, cash, or a combination of those. (Status: This bill is also pending in this committee).
- Arguments in Support. The California Cannabis Industry Association writes, “California law requires that all cannabis and cannabis products distributed and sold in the state be accompanied by a COA, certifying that they have been properly analyzed by a testing laboratory. However, current law does not allow cannabis testing facilities to change any errors once a COA has been submitted. This current process does not account for common, human error, such as spelling mistakes or other typos, and in turn causes bottlenecks in the supply chain.
“This bill offers a simple, straightforward solution by allowing cannabis testing laboratories to submit a form to correct such minor errors. Furthermore, by granting the Bureau authority to ultimately determine what sorts of errors may be corrected, this bill ensures that objective data on COAs pertaining to cannabinoid levels, contaminants, and other compliance factors may not be altered.”
SUPPORT AND OPPOSITION:
Support:
California Cannabis Industry Association (Sponsor)
Drug Policy Alliance
Southern California Coalition
Opposition:
None on file as of May 29, 2019.
-- END --
Date of Hearing: April 10, 2019
ASSEMBLY COMMITTEE ON APPROPRIATIONS
Lorena Gonzalez, Chair
ABPCA Bill Id:AB 404
Author:(Mark Stone) – As Amended Ver:March 19, 2019
Policy Committee: | Business and Professions | Vote: | 20 - 0 |
Urgency: No State Mandated Local Program: No Reimbursable: No
SUMMARY:
This bill allows a cannabis testing laboratory to amend a certificate of analysis to fix minor errors and to retest a sample if the test result falls outside the specifications authorized by law, the Bureau of Cannabis Control authorizes the test and the test was compromised due to equipment malfunction, staff error or other circumstances allowed by the bureau.
FISCAL EFFECT:
Minor and absorbable administrative costs to the BCC within the Department of Consumer Affairs (DCA) to promulgate regulations more clearly defining what constitutes a minor error.
COMMENTS:
- Purpose. According to the sponsors, California Cannabis Industry Association and Etheridge Farms, this bill provides a much-needed technical update to the regulatory process for cannabis testing to permit correction of errors due to laboratory staff error or equipment malfunction. The author indicates the bill will avoid wasteful disposal of otherwise-compliant cannabis products, which can cost manufacturers hundreds of thousands of dollars, and provide consumers with the most accurate possible information about the products they consume.
- Background. In 1996, California voters passed Proposition 215, legalizing the use of medical cannabis in the state. The state began regulating medical cannabis in 2016 and, later that year, California voters passed Proposition 64, which legalized the recreational use of cannabis, beginning in 2018.
Current regulations require testing results to be documented in certificates of analysis, but under current regulations, a certificate cannot be corrected even if it contains a minor error due to a typo or data entry mistake. Similarly, once a certificate is produced, a batch of cannabis products cannot be retested, even if the testing facility is aware of equipment malfunction, miscalibration or other staff error producing an inaccurate result.
Analysis Prepared by: Lisa Murawski / APPR. / (916) 319-2081
Date of Hearing: April 2, 2019
ASSEMBLY COMMITTEE ON BUSINESS AND PROFESSIONS
Evan Low, Chair
ABPCA Bill Id:AB 404
Author:(Mark Stone) – As Amended Ver:March 19, 2019
SUBJECT: Commercial cannabis activity: testing laboratories.
SUMMARY: Allows a cannabis testing laboratory to amend a certificate of analysis to fix minor errors and to retest a sample if the test result falls outside the specifications authorized by law, the Bureau of Cannabis Control authorizes the test, and the test was compromised due to equipment malfunction, staff error, or other circumstances allowed by the Bureau.
EXISTING LAW:
- Establishes the Bureau of Cannabis Control under the Department of Consumer Affairs to administer and enforce the Medicinal and Adult-Use Cannabis Regulation and Safety Act (MAUCRSA) and the Control, Regulate and Tax Adult Use of Marijuana Act of 2016 (AUMA), which establishes a comprehensive system to control and regulate the distribution, transport, storage, and sale of cannabis products. (Business and Professions Code (BPC) § 26000 et seq.)
- Requires licensed sellers of cannabis or cannabis products to have a representative sample tested by a licensed testing laboratory. (BPC § 26100)
- Authorizes a testing laboratory to receive and test samples of cannabis or cannabis products from a qualified patient or primary caregiver, only if the qualifies patient or caregiver presents the qualified patient’s valid physician’s recommendation for cannabis for medicinal purposes. Prohibits a testing laboratory from certifying samples from a qualified patient or primary caregiver for resale or transfer to another party or licensee. Requires all tests performed by a testing laboratory for a qualified patient or primary caregiver to be recorded with the name of the qualified patient or primary caregiver and the amount of cannabis or cannabis product received. (BPC § 26104Defines “certificate of analysis” as the report prepared by the laboratory about the analytical testing performed and results obtained by the laboratory. (California Code of Regulations (CCR), Title 16, § 5700(q)
- Requires a distributor after receipt of a certificate of analysis from a testing laboratory, or upon transfer from another distributor, before transporting the cannabis goods, to ensure, among other things, that the certificate is the proper certificate for the batch, is timely, is consistent with the label on the goods. (CCR, tit. 16, § 5307)
THIS BILL:
- Permits batches of cannabis products to be retested at the written request of the testing facility and with approval by the Bureau of Cannabis Control.
FISCAL EFFECT: Unknown. This bill is keyed fiscal by Legislative Counsel.
COMMENTS:
Purpose. According to the sponsors, California Cannabis Industry Association and Etheridge Farms, “[This bill] provides a much-needed technical update to the regulatory process for cannabis testing to permit correction of errors due to laboratory staff error or equipment malfunction. By allowing amendment of [certificates of analysis] and retesting of batches only with Bureau approval, [this bill] allows the necessary oversight to ensure that these processes are not abused. These provisions will avoid wasteful disposal of otherwise-compliant cannabis products, which can cost manufacturers hundreds of thousands of dollars, and provide consumers with the most accurate possible information about the products they consume.”
Background. California began regulating medical marijuana with the passage of the Compassionate Use Act in 1996, which exempted patients and their primary caregivers from criminal liability under state law for the possession and cultivation of marijuana. In 2003, the Legislature authorized the formation of medical marijuana cooperatives—nonprofit organizations that cultivate and distribute marijuana for medical uses to their members through dispensaries. The Medical Marijuana Regulation and Safety Act (Act) passed in 2015, which created a comprehensive state licensing system for the commercial cultivation, manufacture, retail sale, transport, distribution, delivery, and testing of medical cannabis.
In November 2016 voters approved Proposition 64, which legalized the nonmedical use of cannabis. Under Proposition 64, adults 21 years of age or older can legally grow, possess, and use cannabis for nonmedical purposes, with certain restrictions.
Testing Requirements and Benefits of Testing. Cannabis testing laboratories are required to evaluate the levels of contaminants of cannabis samples, including residual solvent, processing chemicals, foreign material (such as hair and insects) and microbiological impurities.
Testing also determines the concentrations of active chemicals and to ensure compliance with safety standards. The testing results are documented in certificates of analysis, but under current regulations, a certificate cannot be corrected even if it contains a minor error due to a typo or data entry mistake. Similarly, once a certificate is produced, a batch of cannabis products cannot be retested, even if the testing facility is aware of equipment malfunction, miscalibration, or other staff error producing an inaccurate result.
Current Related Legislation.
AB1288 (Cooley) of the current Legislative Session, requires information captured by the cannabis “track and trace” program to include details on the date and location of retail sale to a customer, and requires the Department of Food and Agriculture, in consultation with the Bureau, to ensure that the “track and trace” program is fully integrated into the California Law Enforcement Telecommunications System by July 1, 2020.
AB1458 (Quirk) of the current Legislative Session, makes technical, non-substantive changes to the Business and Professions Code Section 26100, which describes procedures and requirements for testing cannabis and cannabis products.
AB1461 (Quirk) of the current Legislative Session, makes technical, non-substantive changes to the Business and Professions Code Section 26104, which describes several obligations and restrictions relating to cannabis testing laboratories.
SB153 (Wilk) of the current Legislative Session, revises provisions regulating the cultivation and testing of industrial hemp.
Prior Related Legislation.
SB 837 (Budget and Fiscal Review, Chapter 32, Statutes of 2016) clarified that licensed operators may test cannabis and cannabis products in-house for quality assurance purposes.
AB 243 (Wood, Chapter 688, Statutes of 2015) requires CDFA, DPR, the State Department of Public Health, the Department of Fish and Wildlife, and the State Water Resources Control Board to promulgate regulations or standards relating to medical cannabis and its cultivation, as specified, and establishes licensing fees, fines, and penalties.
AB 266 (Bonta et al., Chapter 689, Statutes of 2015) established the Act for the licensure and regulation of medical cannabis and establishes the Bureau of Medical Cannabis Regulation within the DCA.
SB 643 (McGuire, Chapter 719, Statutes of 2015) set standards for the licensed cultivation and physician prescription of medical cannabis; establishes a track and trace program for the transportation of medical cannabis; and authorizes counties to impose a tax on medical cannabis.
ARGUMENTS IN SUPPORT:
According to the sponsors, California Cannabis Industry Association and Etheridge Farms, “[This bill] provides a much-needed technical update to the regulatory process for cannabis testing to permit correction of errors due to laboratory staff error or equipment malfunction. By allowing amendment of COAs and retesting of batches only with Bureau approval, [this bill] allows the necessary oversight to ensure that these processes are not abused. These provisions will avoid wasteful disposal of otherwise-compliant cannabis products, which can cost manufacturers hundreds of thousands of dollars, and provide consumers with the most accurate possible information about the products they consume.”
REGISTERED SUPPORT:
California Cannabis Industry Association (Sponsor)
Etheridge Farms (Sponsor)
REGISTERED OPPOSITION:
None on file.
Analysis Prepared by: Danielle Sires / B. & P. / (916) 319-3301
Bill Author
Bill Co-Author(s):